Table 3 |
|
|
The most frequent initial antibiotic combinations prescribed (described as percentage of patients) |
|
|
Initial antibiotic combination |
Percentage of patients |
|
|
|
|
Baseline period |
|
|
Penicillin IV + roxithromycin |
20.6% |
|
Ceftriaxone |
10.2% |
|
Ceftriaxone + roxithromycin |
9.2% |
|
Penicillin IV |
5.8% |
|
Penicillin IV + doxycycline |
5.3% |
|
Ceftriaxone + erythromycin IV |
4.3% |
|
Academic detailing period |
|
|
Penicillin IV + roxithromycin |
27.4% |
|
Ceftriaxone + roxithromycin |
16.7% |
|
Amoxycillin (oral)+ roxithromycin |
8.3% |
|
Ceftriaxone |
6.9% |
|
Roxithromycin |
5.1% |
|
Penicillin IV + doxycycline |
4.2% |
|
Computerised decision support period |
|
|
Penicillin IV + roxithromycin |
28.6% |
|
Ceftriaxone + roxithromycin |
17.3% |
|
Ceftriaxone + azithromycin |
12.8% |
|
Ceftriaxone |
6.7% |
|
Penicillin IV + doxycycline |
6.0% |
|
|
|
|
Buising et al. BMC Medical Informatics and Decision Making 2008 8:35 doi:10.1186/1472-6947-8-35 |
|
